Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO)

Sepsis is a major cause of mortality during the neutropenic phase after intensive cytotoxic therapies for malignancies. Improved management of sepsis during neutropenia may reduce the mortality of cancer therapies. Clinical guidelines on sepsis treatment have been published by others. However, optim...

Descripción completa

Detalles Bibliográficos
Autores principales: Penack, Olaf, Becker, Carolin, Buchheidt, Dieter, Christopeit, Maximilian, Kiehl, Michael, von Lilienfeld-Toal, Marie, Hentrich, Marcus, Reinwald, Marc, Salwender, Hans, Schalk, Enrico, Schmidt-Hieber, Martin, Weber, Thomas, Ostermann, Helmut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4050292/
https://www.ncbi.nlm.nih.gov/pubmed/24777705
http://dx.doi.org/10.1007/s00277-014-2086-0
_version_ 1782319930936393728
author Penack, Olaf
Becker, Carolin
Buchheidt, Dieter
Christopeit, Maximilian
Kiehl, Michael
von Lilienfeld-Toal, Marie
Hentrich, Marcus
Reinwald, Marc
Salwender, Hans
Schalk, Enrico
Schmidt-Hieber, Martin
Weber, Thomas
Ostermann, Helmut
author_facet Penack, Olaf
Becker, Carolin
Buchheidt, Dieter
Christopeit, Maximilian
Kiehl, Michael
von Lilienfeld-Toal, Marie
Hentrich, Marcus
Reinwald, Marc
Salwender, Hans
Schalk, Enrico
Schmidt-Hieber, Martin
Weber, Thomas
Ostermann, Helmut
author_sort Penack, Olaf
collection PubMed
description Sepsis is a major cause of mortality during the neutropenic phase after intensive cytotoxic therapies for malignancies. Improved management of sepsis during neutropenia may reduce the mortality of cancer therapies. Clinical guidelines on sepsis treatment have been published by others. However, optimal management may differ between neutropenic and non-neutropenic patients. Our aim is to give evidence-based recommendations for haematologist, oncologists and intensive care physicians on how to manage adult patients with neutropenia and sepsis.
format Online
Article
Text
id pubmed-4050292
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-40502922014-06-18 Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO) Penack, Olaf Becker, Carolin Buchheidt, Dieter Christopeit, Maximilian Kiehl, Michael von Lilienfeld-Toal, Marie Hentrich, Marcus Reinwald, Marc Salwender, Hans Schalk, Enrico Schmidt-Hieber, Martin Weber, Thomas Ostermann, Helmut Ann Hematol Review Article Sepsis is a major cause of mortality during the neutropenic phase after intensive cytotoxic therapies for malignancies. Improved management of sepsis during neutropenia may reduce the mortality of cancer therapies. Clinical guidelines on sepsis treatment have been published by others. However, optimal management may differ between neutropenic and non-neutropenic patients. Our aim is to give evidence-based recommendations for haematologist, oncologists and intensive care physicians on how to manage adult patients with neutropenia and sepsis. Springer Berlin Heidelberg 2014-04-29 2014 /pmc/articles/PMC4050292/ /pubmed/24777705 http://dx.doi.org/10.1007/s00277-014-2086-0 Text en © The Author(s) 2014 https://creativecommons.org/licenses/by/4.0/ Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Review Article
Penack, Olaf
Becker, Carolin
Buchheidt, Dieter
Christopeit, Maximilian
Kiehl, Michael
von Lilienfeld-Toal, Marie
Hentrich, Marcus
Reinwald, Marc
Salwender, Hans
Schalk, Enrico
Schmidt-Hieber, Martin
Weber, Thomas
Ostermann, Helmut
Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO)
title Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO)
title_full Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO)
title_fullStr Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO)
title_full_unstemmed Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO)
title_short Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO)
title_sort management of sepsis in neutropenic patients: 2014 updated guidelines from the infectious diseases working party of the german society of hematology and medical oncology (agiho)
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4050292/
https://www.ncbi.nlm.nih.gov/pubmed/24777705
http://dx.doi.org/10.1007/s00277-014-2086-0
work_keys_str_mv AT penackolaf managementofsepsisinneutropenicpatients2014updatedguidelinesfromtheinfectiousdiseasesworkingpartyofthegermansocietyofhematologyandmedicaloncologyagiho
AT beckercarolin managementofsepsisinneutropenicpatients2014updatedguidelinesfromtheinfectiousdiseasesworkingpartyofthegermansocietyofhematologyandmedicaloncologyagiho
AT buchheidtdieter managementofsepsisinneutropenicpatients2014updatedguidelinesfromtheinfectiousdiseasesworkingpartyofthegermansocietyofhematologyandmedicaloncologyagiho
AT christopeitmaximilian managementofsepsisinneutropenicpatients2014updatedguidelinesfromtheinfectiousdiseasesworkingpartyofthegermansocietyofhematologyandmedicaloncologyagiho
AT kiehlmichael managementofsepsisinneutropenicpatients2014updatedguidelinesfromtheinfectiousdiseasesworkingpartyofthegermansocietyofhematologyandmedicaloncologyagiho
AT vonlilienfeldtoalmarie managementofsepsisinneutropenicpatients2014updatedguidelinesfromtheinfectiousdiseasesworkingpartyofthegermansocietyofhematologyandmedicaloncologyagiho
AT hentrichmarcus managementofsepsisinneutropenicpatients2014updatedguidelinesfromtheinfectiousdiseasesworkingpartyofthegermansocietyofhematologyandmedicaloncologyagiho
AT reinwaldmarc managementofsepsisinneutropenicpatients2014updatedguidelinesfromtheinfectiousdiseasesworkingpartyofthegermansocietyofhematologyandmedicaloncologyagiho
AT salwenderhans managementofsepsisinneutropenicpatients2014updatedguidelinesfromtheinfectiousdiseasesworkingpartyofthegermansocietyofhematologyandmedicaloncologyagiho
AT schalkenrico managementofsepsisinneutropenicpatients2014updatedguidelinesfromtheinfectiousdiseasesworkingpartyofthegermansocietyofhematologyandmedicaloncologyagiho
AT schmidthiebermartin managementofsepsisinneutropenicpatients2014updatedguidelinesfromtheinfectiousdiseasesworkingpartyofthegermansocietyofhematologyandmedicaloncologyagiho
AT weberthomas managementofsepsisinneutropenicpatients2014updatedguidelinesfromtheinfectiousdiseasesworkingpartyofthegermansocietyofhematologyandmedicaloncologyagiho
AT ostermannhelmut managementofsepsisinneutropenicpatients2014updatedguidelinesfromtheinfectiousdiseasesworkingpartyofthegermansocietyofhematologyandmedicaloncologyagiho

Ejemplares similares